Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 14,058 | reported | 14 May 2026 | tx 21+123,791 |
| Syros Pharmaceuticals, Inc. | 6,000 | reported | 05 Jun 2024 | tx 10+96,500−4,000 |
| MCKESSON CORP | 301 | reported | 30 Jul 2025 | tx 3+706 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 21 Jul 2021 | tx 9+14,629−14,629 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | reported | 14 May 2008 | tx 33+1,417,314−2,236,331 |
| ALLERGAN INC | 0 | reported | 17 Mar 2015 | tx 253+141,470.18−152,235.46 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,751 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,058 | 0.00 USD | deriv |
| 30 Jul 2025 | GRANT_AWARD | MCKESSON CORP | 301 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,740 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 10,787 | 0.00 USD | deriv |
| 31 Jul 2024 | GRANT_AWARD | MCKESSON CORP | 349 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,345 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,900 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 4,000 | — | |
| 01 Jun 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | MCKESSON CORP | 56 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,860 | 0.00 USD | |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,110 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,300 | 0.00 USD | |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 6,245 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 09 Sept 2021 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 21 Jul 2021 | OTHER | ALEXION PHARMACEUTICALS INC | 14,629 | 0.00 USD | |
| 24 Jun 2021 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,145 | 0.00 USD |